172 related articles for article (PubMed ID: 24810008)
1. The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer.
Parikh AA; Robinson J; Zaydfudim VM; Penson D; Whiteside MA
J Surg Oncol; 2014 Sep; 110(3):227-32. PubMed ID: 24810008
[TBL] [Abstract][Full Text] [Related]
2. Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005.
Robbins AS; Pavluck AL; Fedewa SA; Chen AY; Ward EM
J Clin Oncol; 2009 Aug; 27(22):3627-33. PubMed ID: 19470927
[TBL] [Abstract][Full Text] [Related]
3. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
4. Effects of health insurance and race on colorectal cancer treatments and outcomes.
Roetzheim RG; Pal N; Gonzalez EC; Ferrante JM; Van Durme DJ; Krischer JP
Am J Public Health; 2000 Nov; 90(11):1746-54. PubMed ID: 11076244
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States).
Rogers SO; Ray WA; Smalley WE
Cancer Causes Control; 2004 Mar; 15(2):193-9. PubMed ID: 15017132
[TBL] [Abstract][Full Text] [Related]
6. Treatment variation by insurance status for breast cancer patients.
Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
[TBL] [Abstract][Full Text] [Related]
7. Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer.
Sineshaw HM; Ng K; Flanders WD; Brawley OW; Jemal A
Gastroenterology; 2018 Mar; 154(4):906-915.e7. PubMed ID: 29146523
[TBL] [Abstract][Full Text] [Related]
8. Disparities in pancreas cancer care.
Abraham A; Al-Refaie WB; Parsons HM; Dudeja V; Vickers SM; Habermann EB
Ann Surg Oncol; 2013 Jun; 20(6):2078-87. PubMed ID: 23579872
[TBL] [Abstract][Full Text] [Related]
9. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.
Murphy CC; Harlan LC; Warren JL; Geiger AM
J Clin Oncol; 2015 Aug; 33(23):2530-6. PubMed ID: 26150445
[TBL] [Abstract][Full Text] [Related]
10. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer.
Simpson DR; Martínez ME; Gupta S; Hattangadi-Gluth J; Mell LK; Heestand G; Fanta P; Ramamoorthy S; Le QT; Murphy JD
J Natl Cancer Inst; 2013 Dec; 105(23):1814-20. PubMed ID: 24231453
[TBL] [Abstract][Full Text] [Related]
11. The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer.
Mitsakos AT; Irish W; Parikh AA; Snyder RA
PLoS One; 2022; 17(2):e0263818. PubMed ID: 35176030
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with colon cancer stage at diagnosis.
Halpern MT; Pavluck AL; Ko CY; Ward EM
Dig Dis Sci; 2009 Dec; 54(12):2680-93. PubMed ID: 19117126
[TBL] [Abstract][Full Text] [Related]
13. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.
Fedewa SA; Lerro C; Chase D; Ward EM
Gynecol Oncol; 2011 Jul; 122(1):63-8. PubMed ID: 21463888
[TBL] [Abstract][Full Text] [Related]
14. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old.
Hsu CD; Wang X; Habif DV; Ma CX; Johnson KJ
Cancer; 2017 Aug; 123(16):3125-3131. PubMed ID: 28440864
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Systemic Treatment Use in Advanced-stage Non-Small Cell Lung Cancer by Source of Health Insurance.
Maguire FB; Morris CR; Parikh-Patel A; Cress RD; Keegan THM; Li CS; Lin PS; Kizer KW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1059-1066. PubMed ID: 30842132
[TBL] [Abstract][Full Text] [Related]
17. Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.
Shin JY; Yoon JK; Diaz AZ
J Neurooncol; 2017 Mar; 132(1):89-98. PubMed ID: 27864706
[TBL] [Abstract][Full Text] [Related]
18. Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.
Doll KM; Meng K; Gehrig PA; Brewster WR; Meyer AM
Am J Obstet Gynecol; 2016 Oct; 215(4):447.e1-447.e13. PubMed ID: 27130238
[TBL] [Abstract][Full Text] [Related]
19. Association of Delays in Surgery for Melanoma With Insurance Type.
Adamson AS; Zhou L; Baggett CD; Thomas NE; Meyer AM
JAMA Dermatol; 2017 Nov; 153(11):1106-1113. PubMed ID: 28979974
[TBL] [Abstract][Full Text] [Related]
20. Treatment differences by health insurance among outpatients with coronary artery disease: insights from the national cardiovascular data registry.
Smolderen KG; Spertus JA; Tang F; Oetgen W; Borden WB; Ting HH; Chan PS
J Am Coll Cardiol; 2013 Mar; 61(10):1069-75. PubMed ID: 23375933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
